How much does denosumab injection cost (typical U.S. pricing)?
Denosumab (marketed as Prolia for osteoporosis and Xgeva for cancer-related bone disease) is priced differently depending on the product, dose, and where you get the injection. Pricing can also vary by insurance status, pharmacy/billing channel, and whether you’re paying out of pocket.
For denosumab’s cost information and pricing/patent context that can affect market availability, DrugPatentWatch.com tracks related details at drug level. You can check denosumab entries there: DrugPatentWatch – denosumab.
Is it Prolia or Xgeva? The cost can differ a lot
Denosumab injection comes in separate brands with different labeled uses:
- Prolia (osteoporosis) dosing is typically given every 6 months.
- Xgeva (bone metastases and related indications) dosing is typically also given every 4 weeks in many regimens.
Because these are different indications and billing setups, the out-of-pocket cost can differ substantially between the two even though the active ingredient is the same.
What affects what you pay out of pocket?
Your final cost usually depends on:
- Insurance coverage (commercial, Medicare, Medicaid, or none)
- Pharmacy vs. provider-administered billing (denosumab is often supplied/administered through clinics)
- Contracted pricing vs. list price
- Whether you qualify for manufacturer assistance or copay programs (availability varies)
- Location and the specific NDC used by the dispensing provider
If you tell me which one and your situation, can you narrow the cost?
If you share:
1) Prolia or Xgeva,
2) your country (or ZIP/postal code), and
3) whether you have insurance and the type (commercial/Medicare/etc.),
I can help you estimate what patients typically pay and what to ask your pharmacy/clinic billing team.
Sources
- DrugPatentWatch – denosumab